AbbVie prices new rheumatoid arthritis drug at $59,000 a year
(Reuters) – AbbVie Inc has priced its new rheumatoid arthritis treatment at $59,000 a year after gaining U.S. approval on Friday, a big boost for the drugmaker struggling with rising…
FDA approves Celgene’s bone marrow cancer treatment
(Reuters) – The U.S. Food and Drug Administration on Friday approved Celgene Corp’s Inrebic to treat certain rare forms of bone marrow cancer called myelofibrosis, making it the second approved…
AbbVie prices new rheumatoid arthritis drug at $59,000/yr
(Reuters) – AbbVie Inc has priced its new rheumatoid arthritis treatment at $59,000 a year after gaining U.S. approval on Friday, a big boost for the drugmaker struggling with rising…
Regeneron’s Ebola treatment proves superior to rival in trial
(Reuters) – Regeneron Pharmaceuticals Inc said on Monday its experimental treatment for Ebola proved superior to a rival therapy from Mapp Biopharmaceutical at preventing death, in a trial evaluating four…
Scientists hail promise of first effective Ebola treatments in Congo trial
LONDON (Reuters) – Scientists are a step closer to finding the first effective treatments for the deadly Ebola haemorrhagic fever after two potential drugs showed survival rate of as much…
Sarepta says adverse event report for DMD gene therapy erroneously submitted
(Reuters) – Sarepta Therapeutics Inc said on Thursday it was informed that an adverse event report was erroneously submitted to the U.S. health regulator regarding an ongoing study of the…
Roche’s Tecentriq recommended for EU approval to treat lung cancer form
FILE PHOTO: The logo of Swiss drugmaker Roche is seen at its headquarters in Basel, Switzerland February 1, 2018. REUTERS/Arnd Wiegmann ZURICH (Reuters) – The European Medicine Agency’s Committee for…
European panel okays GW Pharma cannabis drug for epilepsy
(Reuters) – GW Pharmaceuticals’ marijuana-based treatment Epidyolex has won a positive recommendation for marketing approval from a European Medicines Agency (EMA) panel on Friday for use as an additional treatment…
Many deadly common cancers get little charity funding
(Reuters Health) – Many of the most common and lethal cancers get the fewest research dollars from fundraising advocacy groups, especially cancers associated with stigmatized behaviors like smoking and drinking,…
Multidrug-resistant malaria spreading in Southeast Asia: study
FILE PHOTO: Anopheles minimus mosquitoes are pictured at a lab in the Public Health Ministry in Bangkok, Thailand, November 9, 2017. REUTERS/Athit Perawongmetha LONDON (Reuters) – Strains of malaria resistant…